CVS Health Corp (NY:CVS)

3 Stocks That Could Be Kicked Out of the Dow -- and the Companies That May Replace Them ↗

September 19, 2023

Three time-tested yet poor-performing Dow components are at risk of being removed from the index.

Is there anything better than stagflationary pressures on gold prices? A weaker dollar and falling interest rates create a sweet spot for gold.

Topics Stocks

Stagflationary Moves In Bonds And Oil Opens Golden Opportunity ↗

September 18, 2023

Burry's insight and strategic thinking led him to invest in three seemingly disparate industries.

Betting With the ‘Big Short’: 3 Michael Burry Stocks to Bank On ↗

September 15, 2023

These 3 stocks to avoid aren't offering much right now – except uncertainty and massive risk of potential losses.

3 Strong Sell Stocks for September 2023 ↗

September 15, 2023

They are down but not out.

A Look Into CVS Health Inc's Price Over Earnings ↗

September 14, 2023

Via Benzinga

2 Top Stocks to Buy Near Their 52-Week Lows ↗

September 14, 2023

Here's a list of S&P 500 stocks to sell. Each has a unique reason behind its bearish thesis, prompting investors to take action.

Looking Into CVS Health's Recent Short Interest ↗

September 04, 2023

Via Benzinga

3 S&P 500 Stocks to Sell Before a Crash ↗

September 13, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW) used to be "one of the greatest stocks of our time and, it’s now

Topics Stocks

Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD ↗

September 13, 2023

Via Benzinga

These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts ↗

September 13, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

CVS And Cigna Charge $6,000 For $55 Generics, How Do We Fix This? ↗

September 12, 2023

Health insurers dramatically mark up prices of generics and pharmacies are in on the scheme.

According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch ↗

September 12, 2023

Via Benzinga

Amazon Stock ‘Has Something For Everyone’ - Gina Sanchez ↗

September 03, 2023

CVS, Walgreens Boots Among Firms Receiving Warning Letter Against Selling Unapproved Eye Products ↗

11 Analysts Have This to Say About CVS Health ↗

September 01, 2023

Via Benzinga

September 12, 2023

The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products violating fed

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023 ↗

September 12, 2023

Via Benzinga

S&P 500: Tesla, Apple Chipmaker Lead Big Movers ↗

September 11, 2023

Aerospace giant RTX led losers on the benchmark index Monday.

Via Investor's Business Daily

Topics Stocks

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 11, 2023

Via Benzinga

Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis ↗

September 11, 2023

Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has

Via Benzinga

Walmart Contemplates Multi-billion Dollar Majority Stake In ChenMed ↗

September 09, 2023

Walmart Inc. (NYSE: WMT) is reportedly contemplating the

Via Benzinga

The 3 Best Safe Stocks to Buy Now: September 2023 ↗

September 08, 2023

Buying safe stocks despite the market looking healthy is a wise investment decision because there are still signs a recession could occur.

If You'd Invested $25,000 in CVS Health 20 Years Ago, This Is How Much You Would Have Today ↗

Topics Economy

September 07, 2023

Your investment grew nicely, but would investing in CVS have been a better move than simply going with the S&P 500?

Despite the Dow's reputation of consisting of only solid, blue-chip stocks, these three are proving risky and making the list of Dow stocks to sell.

Topics Stocks

3 Dow Stocks to Sell in September Before They Crash and Burn ↗

September 04, 2023

After falling significantly in recent weeks, these excellent dividend stocks look like screaming buys.

Topics Stocks

2 Underappreciated Dividend Stocks to Buy in September and Hold Forever ↗

September 03, 2023

Given its new biosimilars unit, copying Ozempic is more likely than it sounds.

Could CVS Make a Copy of Ozempic? ↗

September 02, 2023

CVS just fired a shot across Viatris' bow.

CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know ↗

September 01, 2023

Spinning up a new division will probably be a boon for shareholders.

CVS Just Made a Major New Announcement, But Should You Buy It? ↗

September 01, 2023

It's a great company, but the yield is nothing special.

Is Federal Realty Investment Trust a Buy? ↗

September 01, 2023

These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential.

3 Undervalued Healthcare Stocks In 2023 ↗

August 31, 2023